Oxidative Stress Inhibits Healthy Adipose Expansion Through Suppression of SREBF1-Mediated Lipogenic Pathway

Recent studies have emphasized the association of adipose oxidative stress (Fat reactive oxygen species [ROS]) with the pathogenesis of metabolic disorders in obesity. However, the causal roles of Fat ROS in metabolic disturbances in vivo remain unclear because no mouse model has been available in which oxidative stress is manipulated by targeting adipocytes. In this research, we generated two models of Fat ROS–manipulated mice and evaluated the metabolic features in diet-induced obesity. Fat ROS–eliminated mice, in which Cat and Sod1 were overexpressed in adipocytes, exhibited adipose expansion with decreased ectopic lipid accumulation and improved insulin sensitivity. Conversely, Fat ROS–augmented mice, in which glutathione was depleted specifically in adipocytes, exhibited restricted adipose expansion associated with increased ectopic lipid accumulation and deteriorated insulin sensitivity. In the white adipose tissues of these mice, macrophage polarization, tissue fibrosis, and de novo lipogenesis were significantly changed. In vitro approaches identified KDM1A-mediated attenuation of sterol-regulatory element-binding transcription factor 1 (SREBF1) transcriptional activities as the underlying mechanism for the suppression of de novo lipogenesis by oxidative stress. Thus, our study uncovered the novel roles of Fat ROS in healthy adipose expansion, ectopic lipid accumulation, and insulin resistance, providing the possibility for the adipocyte-targeting antioxidant therapy.

[1]  R. Cox,et al.  Exploring the Lean Phenotype of Glutathione-Depleted Mice: Thiol, Amino Acid and Fatty Acid Profiles , 2016, PloS one.

[2]  M. Ciriolo,et al.  Glutathione Decrement Drives Thermogenic Program In Adipose Cells , 2015, Scientific Reports.

[3]  K. Clément,et al.  Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity , 2015, Nature Medicine.

[4]  K. Cho,et al.  Flow cytometry analyses of adipose tissue macrophages. , 2014, Methods in enzymology.

[5]  Y. Inagaki,et al.  Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosis , 2014, Nature Communications.

[6]  Fajun Yang,et al.  Regulation of Lipogenic Gene Expression by Lysine-specific Histone Demethylase-1 (LSD1)* , 2014, The Journal of Biological Chemistry.

[7]  Jing Liang,et al.  Destabilizing LSD1 by Jade-2 promotes neurogenesis: an antibraking system in neural development. , 2014, Molecular cell.

[8]  Caroline Tao,et al.  Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. , 2014, Cell metabolism.

[9]  Chi Wang,et al.  The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells. , 2013, Cell reports.

[10]  A. Salmon,et al.  Oxidative damage associated with obesity is prevented by overexpression of CuZn- or Mn-superoxide dismutase. , 2013, Biochemical and biophysical research communications.

[11]  A. Saito,et al.  Obesity-induced endoplasmic reticulum stress causes chronic inflammation in adipose tissue , 2012, Scientific Reports.

[12]  D. McClain,et al.  MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity , 2012, Nature Medicine.

[13]  I. Shimomura,et al.  Expression of activating transcription factor 2 in inflammatory macrophages in obese adipose tissue , 2012, Obesity.

[14]  M. Blüher,et al.  A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism , 2012, Nature.

[15]  T. Funahashi,et al.  Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction. , 2012, Biochemical and biophysical research communications.

[16]  D. Nebert,et al.  Lipid metabolism and body composition in Gclm(-/-) mice. , 2011, Toxicology and applied pharmacology.

[17]  T. Funahashi,et al.  Cross-sectional and longitudinal study of association between circulating thiobarbituric acid-reacting substance levels and clinicobiochemical parameters in 1,178 middle-aged Japanese men - the Amagasaki Visceral Fat Study , 2011, Nutrition & metabolism.

[18]  P. Scherer,et al.  Adipose tissue remodeling and obesity. , 2011, The Journal of clinical investigation.

[19]  U. Klein,et al.  Transcriptional control of adipose lipid handling by IRF4. , 2011, Cell metabolism.

[20]  K. Petersen,et al.  Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. , 2010, Cell metabolism.

[21]  B. Aggarwal,et al.  Oxidative stress, inflammation, and cancer: how are they linked? , 2010, Free radical biology & medicine.

[22]  M. Matsuda,et al.  Human catalase gene is regulated by peroxisome proliferator activated receptor-gamma through a response element distinct from that of mouse. , 2010, Endocrine journal.

[23]  Jimmy D Bell,et al.  Fat distribution in men of different waist girth, fitness level and exercise habit , 2009, International Journal of Obesity.

[24]  D. James,et al.  Insulin resistance is a cellular antioxidant defense mechanism , 2009, Proceedings of the National Academy of Sciences.

[25]  Masayuki Orimo,et al.  A crucial role for adipose tissue p53 in the regulation of insulin resistance , 2009, Nature Medicine.

[26]  P. Neufer,et al.  Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. , 2009, The Journal of clinical investigation.

[27]  Philipp E. Scherer,et al.  Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI , 2008, Molecular and Cellular Biology.

[28]  R. Bibiloni,et al.  Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice , 2008, Diabetes.

[29]  M. Matsuda,et al.  Adipose expression of catalase is regulated via a novel remote PPARgamma-responsive region. , 2008, Biochemical and Biophysical Research Communications - BBRC.

[30]  M. Matsuda,et al.  Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation , 2007, Diabetes.

[31]  P. Froguel,et al.  Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.

[32]  I. Lemieux,et al.  Abdominal obesity and metabolic syndrome , 2006, Nature.

[33]  S. Kihara,et al.  Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. , 2006, Kidney international.

[34]  T. Funahashi,et al.  Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[35]  E. Lander,et al.  Reactive oxygen species have a causal role in multiple forms of insulin resistance , 2006, Nature.

[36]  Remi Rabasa-Lhoret,et al.  The metabolically healthy but obese individual presents a favorable inflammation profile. , 2005, The Journal of clinical endocrinology and metabolism.

[37]  P. Iyengar,et al.  Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy , 2005, Nature Medicine.

[38]  S. Simpson Of Mice . . . , 2004, Science.

[39]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[40]  L. Glimcher,et al.  Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.

[41]  H. Towle,et al.  Mlx Is the Functional Heteromeric Partner of the Carbohydrate Response Element-binding Protein in Glucose Regulation of Lipogenic Enzyme Genes* , 2004, Journal of Biological Chemistry.

[42]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[43]  U. Smith,et al.  Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects* , 2003, Journal of Biological Chemistry.

[44]  Hitoshi Shimano,et al.  Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes DOI 10.1194/jlr.M100417-JLR200 , 2002, Journal of Lipid Research.

[45]  M. Matsuda,et al.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.

[46]  E. A. Sims,et al.  Are there persons who are obese, but metabolically healthy? , 2001, Metabolism: clinical and experimental.

[47]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[48]  T. Burris,et al.  PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. , 1999, Biochemical and biophysical research communications.

[49]  M. Lean,et al.  Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. , 1999, Diabetes care.

[50]  R. Hammer,et al.  Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. , 1998, Genes & development.

[51]  S. Kiechl,et al.  Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. , 1998, Diabetes.

[52]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.

[53]  E. Ferrannini,et al.  Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). , 1997, The Journal of clinical investigation.

[54]  J. Morrow,et al.  A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[55]  E. Ferrannini,et al.  Insulin Resistance and Hypersecretion in Obesity , 2013 .

[56]  Karen Gallagher-Dorval,et al.  Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity. , 2011, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[57]  Jianrong Han,et al.  Nutrition & Metabolism Modulation of Adipocyte Lipogenesis by Octanoate: Involvement of Reactive Oxygen Species , 2006 .

[58]  T. Awata,et al.  The ligands/activators for peroxisome proliferator-activated receptor α (PPARα) and PPARγ increase Cu2+, Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells , 2001 .

[59]  T. Awata,et al.  The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. , 2001, Metabolism: clinical and experimental.

[60]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. , 1997, Nature.